- $992.16m
- $495.09m
- $32.33m
Brief: Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP-Apollo, Tesla, UDR
U.S. STOCKS ON THE MOVE-Paychex, ChampionX, EV stocks
U.S. STOCKS ON THE MOVE-VirTra, GE Vernova, Blackstone
Verve Therapeutics falls after it pauses enrollment in gene editing therapy study
U.S. STOCKS ON THE MOVE-PVH, Verve Therapeutics, Canoo
Verve Therapeutics falls after it pauses enrollment in gene editing therapy study
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels (updated)
Brief: Verve Therapeutics Announces Updates On PCSK9 Program
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels
Brief: Verve Therapeutics Q4 EPS USD -0.69
U.S. STOCKS ON THE MOVE-ResMed, Guidewire Software, Snowflake
U.S. STOCKS ON THE MOVE-Estee Lauder, Union Pacific, Fluence Energy
U.S. STOCKS ON THE MOVE-Dollar Tree, Phillips 66, GameStop
Verve Therapeutics drops on $148 mln equity raise, share placement with Eli Lilly
Brief: Verve Therapeutics Announces Pricing Of Public Offering Of Common Stock And Concurrent Private Placement
U.S. STOCKS ON THE MOVE-Boeing, Booking Holdings, Eli Lilly
Verve Therapeutics slumps to all-time low on questions over gene editing therapy data
U.S. STOCKS ON THE MOVE-Walmart, Lyft, CrowdStrike